Cargando…

Is ZFP57 binding to H19/IGF2:IG-DMR affected in Silver-Russell syndrome?

BACKGROUND: Loss of paternal methylation (LOM) of the H19/IGF2 intergenic differentially methylated region (H19/IGF2:IG-DMR) causes alteration of H19/IGF2 imprinting and Silver-Russell syndrome (SRS). Recently, internal deletions of the H19/IGF2:IG-DMR have been associated with LOM and SRS when pres...

Descripción completa

Detalles Bibliográficos
Autores principales: Sparago, Angela, Cerrato, Flavia, Riccio, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5822596/
https://www.ncbi.nlm.nih.gov/pubmed/29484033
http://dx.doi.org/10.1186/s13148-018-0454-7
_version_ 1783301720610177024
author Sparago, Angela
Cerrato, Flavia
Riccio, Andrea
author_facet Sparago, Angela
Cerrato, Flavia
Riccio, Andrea
author_sort Sparago, Angela
collection PubMed
description BACKGROUND: Loss of paternal methylation (LOM) of the H19/IGF2 intergenic differentially methylated region (H19/IGF2:IG-DMR) causes alteration of H19/IGF2 imprinting and Silver-Russell syndrome (SRS). Recently, internal deletions of the H19/IGF2:IG-DMR have been associated with LOM and SRS when present on the paternal chromosome. In contrast, previously described deletions, most of which cause gain of methylation (GOM) and Beckwith-Wiedemann syndrome (BWS) on maternal transmission, were consistently associated with normal methylation and phenotype if paternally inherited. PRESENTATION OF THE HYPOTHESIS: The presence of several target sites (ZTSs) and three demonstrated binding regions (BRs) for the imprinting factor ZFP57 in the H19/IGF2:IG-DMR suggest the involvement of this factor in the maintenance of methylation of this locus. By comparing the extension of the H19/IGF2:IG-DMR deletions with the binding profile of ZFP57, we propose that the effect of the deletions on DNA methylation and clinical phenotype is dependent on their interference with ZFP57 binding. Indeed, deletions strongly affecting a ZFP57 BR result in LOM and SRS, while deletions preserving a significant number of ZFPs in each BR do not alter methylation and are associated with normal phenotype. TESTING THE HYPOTHESIS: The generation of transgenic mouse lines in which the endogenous H19/IGF2:IG-DMR is replaced by the human orthologous locus including the three ZFP57 BRs or their mutant versions will allow to test the role of ZFP57 binding in imprinted methylation and growth phenotype. IMPLICATIONS OF THE HYPOTHESIS: Similarly to what is proposed for maternally inherited BWS mutations and CTCF and OCT4/SOX2 binding, we suggest that deletions of the H19/IGF2:IG-DMR result in SRS with LOM if ZFP57 binding on the paternal chromosome is affected. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13148-018-0454-7) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5822596
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-58225962018-02-26 Is ZFP57 binding to H19/IGF2:IG-DMR affected in Silver-Russell syndrome? Sparago, Angela Cerrato, Flavia Riccio, Andrea Clin Epigenetics Hypothesis BACKGROUND: Loss of paternal methylation (LOM) of the H19/IGF2 intergenic differentially methylated region (H19/IGF2:IG-DMR) causes alteration of H19/IGF2 imprinting and Silver-Russell syndrome (SRS). Recently, internal deletions of the H19/IGF2:IG-DMR have been associated with LOM and SRS when present on the paternal chromosome. In contrast, previously described deletions, most of which cause gain of methylation (GOM) and Beckwith-Wiedemann syndrome (BWS) on maternal transmission, were consistently associated with normal methylation and phenotype if paternally inherited. PRESENTATION OF THE HYPOTHESIS: The presence of several target sites (ZTSs) and three demonstrated binding regions (BRs) for the imprinting factor ZFP57 in the H19/IGF2:IG-DMR suggest the involvement of this factor in the maintenance of methylation of this locus. By comparing the extension of the H19/IGF2:IG-DMR deletions with the binding profile of ZFP57, we propose that the effect of the deletions on DNA methylation and clinical phenotype is dependent on their interference with ZFP57 binding. Indeed, deletions strongly affecting a ZFP57 BR result in LOM and SRS, while deletions preserving a significant number of ZFPs in each BR do not alter methylation and are associated with normal phenotype. TESTING THE HYPOTHESIS: The generation of transgenic mouse lines in which the endogenous H19/IGF2:IG-DMR is replaced by the human orthologous locus including the three ZFP57 BRs or their mutant versions will allow to test the role of ZFP57 binding in imprinted methylation and growth phenotype. IMPLICATIONS OF THE HYPOTHESIS: Similarly to what is proposed for maternally inherited BWS mutations and CTCF and OCT4/SOX2 binding, we suggest that deletions of the H19/IGF2:IG-DMR result in SRS with LOM if ZFP57 binding on the paternal chromosome is affected. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13148-018-0454-7) contains supplementary material, which is available to authorized users. BioMed Central 2018-02-21 /pmc/articles/PMC5822596/ /pubmed/29484033 http://dx.doi.org/10.1186/s13148-018-0454-7 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Hypothesis
Sparago, Angela
Cerrato, Flavia
Riccio, Andrea
Is ZFP57 binding to H19/IGF2:IG-DMR affected in Silver-Russell syndrome?
title Is ZFP57 binding to H19/IGF2:IG-DMR affected in Silver-Russell syndrome?
title_full Is ZFP57 binding to H19/IGF2:IG-DMR affected in Silver-Russell syndrome?
title_fullStr Is ZFP57 binding to H19/IGF2:IG-DMR affected in Silver-Russell syndrome?
title_full_unstemmed Is ZFP57 binding to H19/IGF2:IG-DMR affected in Silver-Russell syndrome?
title_short Is ZFP57 binding to H19/IGF2:IG-DMR affected in Silver-Russell syndrome?
title_sort is zfp57 binding to h19/igf2:ig-dmr affected in silver-russell syndrome?
topic Hypothesis
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5822596/
https://www.ncbi.nlm.nih.gov/pubmed/29484033
http://dx.doi.org/10.1186/s13148-018-0454-7
work_keys_str_mv AT sparagoangela iszfp57bindingtoh19igf2igdmraffectedinsilverrussellsyndrome
AT cerratoflavia iszfp57bindingtoh19igf2igdmraffectedinsilverrussellsyndrome
AT riccioandrea iszfp57bindingtoh19igf2igdmraffectedinsilverrussellsyndrome